Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$479.63 USD

479.63
739,792

-6.99 (-1.44%)

Updated Oct 3, 2024 04:00 PM ET

After-Market: $479.67 +0.04 (0.01%) 5:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (59 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Is Intuitive Surgical (ISRG) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (ISRG) Outperforming Other Medical Stocks This Year?

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

by Zacks Equity Research

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Reasons to Hold on to AMN Healthcare (AMN) Stock for Now

by Zacks Equity Research

Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.

Stryker (SYK) Hits New 52-Week High: What's Driving It?

by Zacks Equity Research

Investors are optimistic about Stryker's (SYK) strength in robotics and its diversified product portfolio.

TransMedics (TMDX) Receives FDA Nod for OCS Heart System

by Zacks Equity Research

TransMedics' (TMDX) OCS Heart System is expected to enable broader use of donor hearts for transplantation in the United States.

Urmimala Biswas headshot

3 MedTech Sectors Benefiting Despite COVID-19 Resurgence

by Urmimala Biswas

Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.

Here's Why You Should Invest In Henry Schein (HSIC) Now

by Zacks Equity Research

Investors are optimistic about Henry Schein (HSIC) owing to strong segmental performance and strategic buyouts and collaborations.

Insulet (PODD) Gains on Omnipod Sales Amid Cost Pressure

by Zacks Equity Research

Insulet (PODD) is gradually improving with respect to seamless supply chain and manufacturing operations.

Masimo's (MASI) ORi Favored by New Study For ICU Patients' ETI

by Zacks Equity Research

Masimo's (MASI) ORi is expected to provide early warnings of impending hypoxemia during the ETI procedure, thus aiding in averting any adverse incident.

Here's Why You Should Add STERIS (STE) to Your Portfolio Now

by Zacks Equity Research

STERIS (STE) ended first-quarter fiscal 2022 with better-than-expected results and strong segmental performance, driving the top line.

Zimmer Biomet (ZBH) Hurt by EMEA's Slow Recovery Amid Pandemic

by Zacks Equity Research

Zimmer Biomet's (ZBH) leveraged capital structure is an added concern.

Thermo Fisher (TMO) Gains Government Contract for Pipette Tip

by Zacks Equity Research

Thermo Fisher (TMO) will co-invest with the U.S. government to build a new manufacturing center for pipette tips in North Carolina.

Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) closed at $1,071.53 in the latest trading session, marking a +0.83% move from the prior day.

What Makes Intuitive Surgical, Inc. (ISRG) a New Strong Buy Stock

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Veeva (VEEV) MedTech Suite to Aid B. Braun Speed Up Trials

by Zacks Equity Research

Adoption of Veeva's (VEEV) unified suites of cloud applications is likely to provide a significant boost to the company's Veeva Development Cloud business.

BD's (BDX) Latest Diagnostic System to Improve Lab Efficiency

by Zacks Equity Research

BD's (BDX) new system is expected to address labs' needs for high-volume processing and increases in efficiency.

Reasons to Hold on to Veeva Systems (VEEV) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.

Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) closed at $1,036.52 in the latest trading session, marking a -0.55% move from the prior day.

Here's Why You Should Retain Integra (IART) Stock for Now

by Zacks Equity Research

Solid performance across the CSS and Tissue Technologies segments is driving the top line for Integra (IART).

Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for TIBSOVO

by Zacks Equity Research

Thermo Fisher (TMO) receives FDA go-ahead for the Oncomine Dx Target Test as a CDx for Servier's ivosidenib tablets, TIBSOVO.

SmileDirectClub (SDC) Reels Under Rising Costs, Debt Woes

by Zacks Equity Research

SmileDirectClub (SDC) sees net operating cash outflow in the second quarter.

BD (BDX) Veritor At-Home COVID-19 Test Receives EUA From FDA

by Zacks Equity Research

EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Here's Why You Should Invest In Tandem Diabetes (TNDM) Now

by Zacks Equity Research

Continued adoption of Tandem Diabetes' (TNDM) t:slim X2 technology and international expansion of the Control-IQ technology add to the company's solid second-quarter performance.

Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (ISRG) Outperforming Other Medical Stocks This Year?